NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
08 October 2024
| Name: | LIFESPOT HEALTH LTD (LSH) (This company subsequently changed its name to INHALERX LIMITED. You should refer to that name for Status.) | ||||||
| ISIN: | AU000000LSH7 | ||||||
| Date of Listing: | 11 January 2017 | ||||||
| Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to INHALERX LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 611 845 820ABN: 90 611 845 820
Registration Date: 13 April 2016
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now INHALERX LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| INHALERX LIMITED | 06/10/2021 | |
| LIFESPOT HEALTH LTD | 06/10/2021 |
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to InhaleRx Limited | 06/10/2021 |
The suspension of trading in the securities of Lifespot Health will be lifted from the commencement of trading on Friday, 2 October 2020, following the release by LSH of an announcement regarding a capital raising. | 02/10/2020 |
The company releases an Appendix 2A. | 02/10/2020 |
The company has issued 24,000,000 ordinary shares A$0.04 (4 cents) per share to Cannvalate Pty Ltd raising $960,000. Funds raised will be used to fund clinical trials on the Company's Medihale inhaler device and other novel cannabinoid inhalational devices, completion of the final stages of a BodyTel Fevertel workplace SaaS solution and ongoing marketing of the Fevertel home and workplace products. The company intends to allocate $770,000 towards the inhaler device clinical trials and $190,000 towards the BodyTel Fevertel product development and marketing costs. | 02/10/2020 |
The securities of Lifespot Health Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of LSH, pending the release of an announcement regarding a capital raising. | 28/09/2020 |
listed entity carried for record purposes only | 11/01/2017 |
name changed to InhaleRx Limited | 06/10/2021 |
The suspension of trading in the securities of Lifespot Health will be lifted from the commencement of trading on Friday, 2 October 2020, following the release by LSH of an announcement regarding a capital raising. | 02/10/2020 |
The company releases an Appendix 2A. | 02/10/2020 |
The company has issued 24,000,000 ordinary shares A$0.04 (4 cents) per share to Cannvalate Pty Ltd raising $960,000. Funds raised will be used to fund clinical trials on the Company's Medihale inhaler device and other novel cannabinoid inhalational devices, completion of the final stages of a BodyTel Fevertel workplace SaaS solution and ongoing marketing of the Fevertel home and workplace products. The company intends to allocate $770,000 towards the inhaler device clinical trials and $190,000 towards the BodyTel Fevertel product development and marketing costs. | 02/10/2020 |
The securities of Lifespot Health Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of LSH, pending the release of an announcement regarding a capital raising. | 28/09/2020 |
listed entity carried for record purposes only | 11/01/2017 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 24/08/2021 | Darryl Davies | 1,025,000 | $0.098 | $99,927 |
| 28/11/2019 | Rodney Hannington | 132,267 | $0.039 | $5,087 |
| 31/10/2019 | Rodney Hannington | 100,000 | $0.050 | $5,000 |
| 09/10/2018 | Rodney Hannington | 77,739 | $0.087 | $6,724 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Sean Williams | Non Exec Chairman | 27/07/2021 |
| Matthew Golden | CEO | 12/10/2020 |
| Darryl Davies | Non Exec Director | 20/07/2021 |
| Andrew Saich | Non Exec Director | 20/07/2021 |
| Nova Taylor | Company Secretary | |
| Elizabeth Spooner | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Rodney Hannington | Non Exec Chairman, Independent Director | 12/04/2018 | 27/07/2021 |
| Frank Cannavo | Non Exec Director | 11/01/2017 | 20/07/2021 |
| Justyn Stedwell | Director | 29/03/2018 | 20/07/2021 |
| Andreas Empl | Non Exec Director | 13/01/2020 | 19/05/2020 |
| Greg Plunkett | Independent Director | 11/09/2018 | 13/01/2020 |
| Heinrich Emden | Executive Director | 11/01/2017 | 01/02/2019 |
| David Mandel | Non Exec Chairman | 01/11/2017 | 29/03/2018 |
| Philippa Lewis | Chairman | 01/09/2017 | 01/11/2017 |
| Mark Talbot | Non Exec Director | 11/01/2017 | 01/11/2017 |
| Tilo Brandis | Non Exec Chairman | 11/01/2017 | 31/08/2017 |
| Philip Bekhor | Non Exec Director | 11/01/2017 | 31/08/2017 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
